Cannabidiol (CBD) is one of more than 100 cannabinoids present in the marijuana plant. It is an oil soluble molecule that is known to mitigate inflammation without delivering the ‘high’
produced by its cannabinoid cousin THC. The literature does talk about CBD’s systemic role of softening or counter balancing the effects of THC in the user.

Research based evidence is enjoying a rebirth around the marijuana plant as it has long been known (or suspected) of producing positive neurological effects to patients suffering from such discomfort. Conditions like seizure disorders, Alzheimers, Parkinson’s, arthritis, PTSD, anxiety and others are all undergoing vigorous study to determine the targeted benefits of CBD
therapy.

Xceptol created a patent pending process that involves attaching the oil soluble CBD molecule to a water soluble (or water dispersible) carrier to produce an enhanced level of performance to the guest molecule. CiBiDinol is the result of this research and the resulting products’ topical performance has been laboratory tested with results showing much greater amounts of penetration when compared to the ubiquitous CBD Oil on the market today.

CiBiDinol provides delivery, enhanced activity and a  magnified ability to get much more benefit from much less CBD keeping costs down and manageable. The creams and lotions presented at this time have been formulated by cosmetic research chemists with over 60 years of experience. The lotions are elegant, skin healthy, effective and affordable.

Xcepto1 was born as something of a perfect storm. Owner Mark has suffered from chronic pain for coming close. to 40 years now. The price of medicine has skyrocketed while the wealth to big pharma (and the government officials they pay) has risen off the charts. Ultimately the lack of therapeutic alternatives most beneficial to the patient created the platform to form Xcepto1.

We believe strongly in ‘first do no harm’. Harsh, side effect laden medicines that often lead to multiple therapies do harm. Skyrocketing drug prices and increasingly expensive insurance premiums do harm. We seek to improve quality of life, help patients learn and understand alternative treatment options and responsibly provide those treatments so the patient can afford them and gain a measure of control over their own state of health.

Xceptol’s mission is to continue utilizing our CiBiDinol technology and to continue to develop new technology to provide specific treatments for a variety of maladies in formats that don’t compromise the patient while providing relief and curative benefits that are positive for overall quality of life.